Digital Pathology Market Set to Surpass US$ 6 Bn Mark by 2021Pathologists continue to play a crucial role in detection and diagnosis of a broad range of diseases and consequently guide treatment options. The process is no different for the recent novel coronavirus infection. However, the need for social distancing, self-quarantining, and flattening the curve is forcing to move away from conventional pathology operations to remote technologies. As a result, demand for digital pathology from hospitals, clinics, and contract research organizations (CROs) is moving on an upward swing, as it is pivotal in enabling pathologists maintain their operations during the COVID-19 pandemic. According to a recent report by Future Market Insights, the digital pathology market value is expected to cross its US$ 6 Bn mark by 2021.
Key Factors Shaping the Digital Pathology Market
Increased Spending on Cancer Diagnostics and Monitoring
Growing incidence of cancer is resulting in increased reimbursement spending by governments of various countries globally. Complications arising due to late diagnosis of cancer, especially with regard to blood cancer and lung cancer, are resulting in need for more expensive treatments and medical procedures. The commercial success of digital pathology in research activities is driving demand for these systems from the cancer research sector and is also attracting investments on digital pathology systems for clinical diagnostics applications.
To curb the cancer wave, government in some countries are spending substantially on cancer diagnostic services and campaigns. According to National Health Society (NHS), U.K., cancer services incur a cost of around US$ 8.3 Bn to NHS, of which, majority of this amount is spent on diagnosis and monitoring during 2018. This shows the potential for digital pathology industry in cancer diagnostic and monitoring in future.
Increasing Preference for Outsourcing R&D
The biopharmaceutical industry has experienced substantial numbers of patent expiration in the last decade. This has increased the demand for biosimilar research and developments, especially for cancer treatment. Hence, increasing research and development activities in cancer research has significantly driven growth of the pathology industry in the recent past.
Pharmaceutical companies are allocating tasks of biosimilar development to Contract Research Organizations (CROs), in-vitro diagnostics (IVD) companies, clinical laboratories, regulatory consultants, and Contract Manufacturing Organizations (CMOs), and these companies are improvising to provide more cost effective solutions to clients, thus leading to increasing adoption of digital pathology technologies.
Greater Emphasis on New Product Developments
The digital pathology industry is evolving at a rapid pace and is expected to favor companies that have primary focus on product development during the forecast period. Manufacturers engaged in the development of novel digital pathology solutions are focusing on introducing highly advanced and more user-friendly instruments to meet the varying needs of consumers.
A majority of major players in this industry are focusing on the commercialization of cost effective digital pathology systems in order to exhibit their core competencies in small scale pathologies. Moreover, these companies are also focusing on integrating with cloud service providers to provide total services to consumers. For example, in October 2019, Sectra introduced digital pathology solution software solutions with Software Point LIMS (Laboratory Information Management System).
Digital Pathology Market Structure Analysis
- Some of the market leaders roughly capture around 60% revenue share in market and include Danaher Corporation, F. Hoffmann-La Roche AG, and Huron Technologies International, Inc.
- Major digital pathology vendor companies are entering into strategic alliances with each other, with the objective to enhance their product offerings and to expand their product portfolios. This is turn will enable these players to increase their brand presence in the global market.
- Manufacturers of digital pathology solutions are consistently making changes in their software category platform, to enhance the capabilities of digital pathology image analysis range of solutions to their clients.
Base year considered
Actual estimates/Historical data
2014 - 2018
2019 - 2029
Value (US$) Mn
Component Type, Application, End-User, and Region
North America (U.S. & Canada), Europe (U.K., Germany, France, Spain, Italy, Russia, and Rest of Europe), Latin America (Brazil, Mexico, and Rest of LA), East Asia (China, Japan and South Korea) South Asia (India, Indonesia, Malaysia, Thailand and Rest of South Asia), Oceania (Australia and New Zealand) and MEA (GCC, South Africa, Turkey, and Rest of MEA)
Danaher Corporation, F. Hoffmann-La Roche AG, Huron Technologies International, Inc., Koninklijke Philips N.V., Olympus Corporation, Hamamatsu Photonics K.K., Carl Zeiss AG, Nikon Corporation, 3DHISTECH Ltd., Hologic Inc., PerkinElmer, Inc., Visiopharm, OptraSCAN, Inc., Inspirata, Inc., and Sectra AB.
Revenue forecast, volume analysis, pricing analysis, company share, competitive landscape, growth factors, and trends
Equipment Captures 50% of Total RevenueDigital pathology equipment continues to witness higher demand and investments than software and services. Whole slide scanners remain highly preferred among end users, while tissue microarrays are expected to gain significant traction as a valuable screening tool used in translation research. Innovations are also forthcoming to match the advances in diagnostic software and the advent of AI and automated diagnosis. To tap into opportunities offered the COVID-19 outbreak, market players are working on improving their service offerings with greater emphasis on consulting services which are expected to overtake the need for installation and integration services by 2022.
Developed Regions Take the Center Stage
Growth prospects of the digital pathology market remain high in North America and Europe, given the concentration of leading market players such as PerkinElmer Inc., Koninklijke Philips N.V., Ventana Medical Systems Inc., and Leica Biosystems in these regions. In addition to collaborating with the U.S. government to ramp up the production of medical ventilators, Philips as well as Leica Biosystems received digital pathology FDA waivers to allow pathologists use their technologies to work remotely during the COVID-19 pandemic. Moreover, as the pandemic’s epicenter shifts from China to the U.S. and Italy, market players are specifically focused on these countries in the current scenario.
Optimal Remote Operations to Break Down Regulatory Barriers - Future Growth Lever
Remote operations in the field of pathology have long been difficult, in the view of reliance on physical glass slides and strict regulatory requirements. However, the scenario is changing amidst the outbreak of COVID-19 - mandating pathology organizations to perform the complex and time-consuming validation requirement to read cases at home. As the pandemic crisis unfolds across multiple countries, regulatory requirements for the deployment of digital pathology equipment and services are being broken down which is likely to open a new widow of opportunities. Further, advantages of digital pathology in saving time on commutes and accessing cases on-demand are expected to offer tailwinds to future market growth.
Equipment remains the bestselling category
Adoption of services to see a quantum leap
Clinical pathology remains a prominent application area
Use in drug development to pick significant pace
Hospitals remain top end user
Adoption in clinics grows considerably
How Growth will Unfold
Over the years, digital pathology has provided a novel platform for clinical pathology, facilitating convenient and reliable data sharing among scientists and laboratory technicians for diagnostics and multi-research pathology studies. Adoption in clinical pathology accounts for over 30% of the total market revenue, while stakeholders are capitalizing on drug development application amidst the trend of personalized medicine. Moreover, revenue generated from the use of digital pathology in drug development is expected to surpass that of basic research & applied application by 2026. Furthermore, key market players focusing on advanced technologies to enable efficient remote operations in the time of public health crisis are likely to be rewarded in the long run.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
A recent market study published by Future Market Insights (FMI) on the digital pathology market including global industry analysis for 2014-2018 & opportunity assessment for 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with maximum precision.
Digital Pathology Market Taxonomy
The global digital pathology market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- Whole Slide Scanners
- Brightfield Slide Scanners
- Fluorescence Slide Scanners
- Combination Slide Scanners
- Clinical Microscope
- Tissue Microarrays
- Whole Slide Scanners
- Image Viewing and Analysis Softwares
- Digital Pathology Information Systems
- Image Viewing and Analysis Softwares
- Installation and Integration Services
- Consulting Services
- Maintenance and Validation Services
- Clinical Pathology
- Molecular Diagnostics
- Basic & Applied Research
- Drug Development
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Research Institutes
- Contract Research Organizations (CROs)
- North America
- Latin America
- East Asia
- South Asia
The report initiates with the executive summary of the market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the market.
Readers can find the definition and a detailed segmentation of the digital pathology market in this chapter, which will help them understand the basic information about the market.
This chapter highlights the key trends impacting the growth of the market over the forecast period. This chapter helps reader to understand both supply side and demand side trends of market.
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the digital pathology market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
This section includes premium insights such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the market.
This section explains the global market volume analysis and forecast for the market between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the volume by equipment type.
This section highlights the global pricing analysis by equipment type. This section helps reader to understand the pricing variation of whole slide scanner in various geography.
This section explains the global market value analysis and forecast for the during the forecast period. This chapter includes a detailed analysis of the historical market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2029).
Based on component type, the market is segmented systems, softwares and services. In this chapter, readers can find information about the key trends and developments in digital pathology and market attractiveness analysis based on component type.
This chapter provides details about the digital pathology market based on application, and has been classified into clinical pathology, molecular diagnostics, basic & applied research, drug development, others. In this chapter, readers can understand the market attractiveness
This chapter provides details about the market based on end user, and has been classified into hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, forensic laboratories, research institutes, contract research organizations (CROs), clinics. In this chapter, readers can understand the market attractiveness analysis based on end user.
This chapter explains how the digital pathology market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of growth of the North America market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.
This chapter provides the growth scenario of the market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
This chapter provides the growth scenario of the market in Europe in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.
This chapter highlights the growth of the market in East Asia by focusing on China, Japan & South Korea. This section also help readers understand the key factors that are responsible for the growth of the digital pathology market in East Asia.
This chapter provides the growth scenario of the market in South Asia in several countries such as India, Thailand, Indonesia, Malaysia and rest of South Asia are included in this chapter.
This chapter highlights the growth of the market in Oceania. This section also help readers understand the key factors that are responsible for the growth of the market in Australia and New Zealand.
This chapter provides information about how the market will grow in major countries in the MEA region such as GCC Countries, South Africa, Turkey and the Rest of MEA, during the forecast period.
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in digital pathology market.
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Danaher Corporation, F. Hoffmann-La Roche AG, Huron Technologies International, Inc., Koninklijke Philips N.V., Olympus Corporation, Hamamatsu Photonics K.K., Carl Zeiss AG, Nikon Corporation, 3DHISTECH Ltd., Hologic Inc., PerkinElmer, Inc., Visiopharm, OptraSCAN, Inc., Inspirata, Inc., Sectra AB and among others.
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the digital pathology market report.
This chapter help readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the market.
How the research was conducted?
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Sales Executives
- Industry Experts
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Strategic Growth Initiatives
- Near-term and long-Term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
Primary Interview Splits